Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (286)
Cancellation by sponsor (126)
Prescription medicine registration (12)
Australian Public Assessment Report (AusPAR) (6)
Prescription medicine decision summary (2)

Date

2024 (46)
2023 (45)
2022 (29)
2021 (13)
2020 (31)
2019 (59)
2018 (17)
2017 (14)
2016 (18)
2015 (23)
2014 (8)
2013 (26)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (13)
2006 (26)
2002 (2)
2001 (3)
1994 (7)
1992 (3)
1991 (7)

Results for "[search-keyword]"

Search

Sponsor content

432 result(s) found, displaying 241 to 250

Fresenius Kabi Australia Pty Limited - Blood cell processing unit set Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Blood collection/cell-culture container Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Blood donor set, quad pack Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Haematological separator, cell/plasma Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Filter, blood transfusion Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Suction system filter, smoke plume particulate Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Filter, bacteria, suction unit Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Holder Cancelled under Section 41GL(d) of the Act

14 June 2019

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FLUMAZENIL KABI flumazenil 0.5 mg/5 mL solution for injection ampoules (260016)

25 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FLUMAZENIL KABI flumazenil 0.5 mg/5 mL solution for injection ampoules.
FLUMAZENIL KABI flumazenil 1 mg/10 mL solution for injection ampoules (260017)

25 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FLUMAZENIL KABI flumazenil 1 mg/10 mL solution for injection ampoules.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.